Abstract
Background. Diabetic retinopathy has been shown to be directly associated with the degree and duration of hyperglycemia, and advanced glycosylation end products (AGEs) have been implicated in this pathological process. The purpose of the experiments reported here was to study the effect of AGE deposition on retinal vascular damage which leads to diabetic retinopathy.
Methods. Intravenous injection of exogenous AGEs was used to treat wild-type non-diabetic Sprague–Dawley rats. One of the two retinal slides from each animal was treated using immunohistochemical staining to label retinal vascular AGE deposition, the other H&E staining for counting of capillary pericytes. The results were compared with the findings in untreated wild-type and diabetic controls and in rats treated with unmodified rat serum albumin (RSA).
Results. After 2 weeks of continuous treatment, AGEs were identified in the retinal vascular tissue of the AGE-RSA-injected group. The average number of retinal capillary pericytes per 10×100 microscope power field was 4.313±0.34 (mean ± SD) in the AGE-RSA-injected group, compared with 5.798±0.481 in the control group (P<0.01).
Conclusion. These experiments demonstrate that AGEs, independent of other metabolic factors, can induce vascular change resembling that of diabetic retinopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Xu, X., Li, Z., Luo, D. et al. Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy. Graefe's Arch Clin Exp Ophthalmol 241, 56–62 (2003). https://doi.org/10.1007/s00417-002-0575-7
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00417-002-0575-7